[1] American Diabetes Association (2010) Standards of Medical Care in Diabetes-2010. Diabetes Care, 33, S11-S61. http://dx.doi.org/10.2337/dc10-S011
[2] Chaudhuri, A., Rosenstock, J., DiGenio, A., Meneghini, L., Hollander, P., McGill, J.B., et al. (2012) Comparing the Effects of Insulin Glargine and Thiazolidinediones on Plasma Lipids in Type 2 Diabetes: A Patient-Level Pooled Analysis. Diabetes/Metabolism Research and Reviews, 28, 258-267.
http://dx.doi.org/10.1002/dmrr.1305
[3] Morgan, C.L., Jenkins-Jones, S., Evans, M., Barnett, A.H., Poole, C.D. and Currie, C.J. (2012) Weight Change in People with Type 2 Diabetes: Secular Trends and the Impact of Alternative Antihyperglycaemic Drugs. Diabetes, Obesity and Metabolism, 14, 424-432.
http://dx.doi.org/10.1111/j.1463-1326.2011.01552.x
[4] Pinelli, N.R. and Hurren, K.M. (2011) Efficacy and Safety of Long-Acting Glucagon-Like Peptide-1 Receptor Agonists Compared with Exenatide Twice Daily and Sitagliptin in Type 2 Diabetes Mellitus: A Systematic Review and MetaAnalysis. The Annals of Pharmacotherapy, 45, 850-860.
http://dx.doi.org/10.1345/aph.1Q024
[5] Bolinder, J., Lunggren, O., Kulberg, J., Johansson, L., Wilding, J., Langkilde, A.M., et al. (2012) Effects of Dapagliflozin on Body Weight, Total Fat Mass, and Regional Adipose Tissue Distribution in Patients with Type 2 Diabetes Mellitus with Inadequate Glycemic Control on Metformin. The Journal of Clinical Endocrinology Metabolism, 97, 1020-1031. http://dx.doi.org/10.1210/jc.2011-2260
[6] Feldstein, A.C., Nichols, G.A., Smith, D.H., Stevens, V.J., Bachman, K., Rosales, A.G. and Perrin, N. (2008) Weight Change in Diabetes and Glycemic and Blood Pressure Control. Diabetes Care, 31, 1960-1965. http://dx.doi.org/10.2337/dc08-0426
[7] Anderson, J.W., Kendall, C.W.C. and Jenkins, D.J.A. (2003) Importance of Weight Management in Type 2 Diabetes: Review with Meta-Analysis of Clinical Studies. The Journal of the American College of Nutrition, 22, 331-339. http://dx.doi.org/10.1080/07315724.2003.10719316
[8] Grandy, S., Fox, K.M., Hardy, E., for the SHIELD Study Group (2012) Association of Weight Loss and Medication Adherence among Adults with Type 2 Diabetes Mellitus: SHIELD (Study to Help Improve Early Evaluation and Management of Risk Factors Leading to Diabetes). Current Therapeutic Research, 75, 77-82. http://dx.doi.org/10.1016/j.curtheres.2013.06.004
[9] Diabetes Prevention Program Research Group (2012) Long-Term Safety, Tolerability, and Weight Loss Associated with Metformin in the Diabetes Prevention Program Outcomes Study. Diabetes Care, 35, 731-737. http://dx.doi.org/10.2337/dc11-1299
[10] Grandy, S., Fox, K.M. and Bazata, D.D. (2012) Association of Self-Reported Weight Change and Quality of Life, and Exercise and Weight Management Behaviors among Adults with Type 2 Diabetes Mellitus: The SHIELD Study. Cardiology Research and Practice, 2012, Article ID: 892564.
http://dx.doi.org/10.1155/2012/892564
[11] Bays, H.E., Chapman, R.H., Grandy, S., for the SHIELD Investigators’ Group. (2007) The Relationship of Body Mass Index to Diabetes Mellitus, Hypertension and Dyslipidaemia: Comparison of Data from Two National Surveys. International Journal of Clinical Practice, 61, 737-747.
http://dx.doi.org/10.1111/j.1742-1241.2007.01336.x
[12] Bays, H.E., Bazata, D.D., Clark, N.G., Gavin 3rd, J.R., Green, A.J., Lewis, S.J., et al. (2007) Prevalence of Self-Reported Diagnosis of Diabetes Mellitus and Associated Risk Factors in a National Survey in the US Population: SHIELD (Study to Help Improve Early Evaluation and Management of Risk Factors Leading to Diabetes). BMC Public Health, 7, 277. http://dx.doi.org/10.1186/1471-2458-7-277
[13] US Census Bureau (2003) Annual Supplement to the Current Population Survey: Census Bureau Resident Population Estimates of the United States. US Census Bureau, Washington DC.
[14] Kroenke, K., Spitzer, R.L. and Williams, J.B.W. (2001) The PHQ-9: Validity of a Brief Depression Severity Measure. Journal of General Internal Medicine, 16, 606-613.
http://dx.doi.org/10.1046/j.1525-1497.2001.016009606.x
[15] Blissmer, B., Riebe, D., Dye, G., Ruggiero, L., Greene, G. and Caldwell, M. (2006) Health-Related Quality of Life Following a Clinical Weight Loss Intervention among Overweight and Obese Adults: Intervention and 24 Month Follow-Up Effects. Health and Quality of Life Outcomes, 4, 43.
http://dx.doi.org/10.1186/1477-7525-4-43
[16] Samsa, G.P., Kolotkin, R.L., Williams, G.R., Nguyen, M.H. and Mendel, C.M. (2001) Effect of Moderate Weight Loss on Health-Related Quality of Life: An Analysis of Combined Data from 4 Randomized Trials of Sibutramine vs Placebo. American Journal of Managed Care, 7, 875-883.